Ticker

TORONTO, Feb. 23, 2026 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (CSE: MDMA)(OTCQB: MDXXF), a biotechnology company focused on the research, development, and manufacturing of LaNeo™ MDMA and novel derivatives of MDMA (MDXX class molecules), announced that it has executed a binding supply agreement with Amsterdam University Medical Center (“Amsterdam UMC”) in the Netherlands for the provision of LaNeo™ 40mg…

Shares of United Microelectronics Corporation (NYSE: UMC - Get Free Report) have earned an average recommendation of "Hold" from the seven ratings firms that are covering the company, MarketBeat.com reports. Three equities research analysts have rated the stock with a sell recommendation, two have assigned a hold recommendation and two have given a strong buy recommendation

TAIPEI, Taiwan--(BUSINESS WIRE)--United Microelectronics Corporation (NYSE: UMC; TWSE: 2303) (“UMC”), today reported unaudited net sales for the month of January 2026. Revenues for January 2026 Period 2026 2025 Y/Y Change Y/Y (%) January 20,862,150 19,806,795 1,055,355 5.33% Jan.-Jan. 20,862,150 19,806,795 1,055,355 5.33% (*) All figures in thousands of New Taiwan Dollars (NT$), except for percentages (**) All…

United Microelectronics Corporation (NYSE: UMC - Get Free Report)'s share price gapped down prior to trading on Thursday after BNP Paribas Exane downgraded the stock from a neutral rating to an underperform rating. The stock had previously closed at $11.38, but opened at $10.71. BNP Paribas Exane now has a $8.60 price target on the stock.

United Microelectronics Corporation (NYSE: UMC - Get Free Report)'s stock price hit a new 52-week high during trading on Wednesday following a stronger than expected earnings report. The stock traded as high as $12.68 and last traded at $12.5110, with a volume of 26892402 shares. The stock had previously closed at $11.33. The semiconductor company reported